Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

BACKGROUND: No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824845/
https://www.ncbi.nlm.nih.gov/pubmed/23975660
http://dx.doi.org/10.1007/s40263-013-0102-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824845/
https://www.ncbi.nlm.nih.gov/pubmed/23975660
http://dx.doi.org/10.1007/s40263-013-0102-x

Ejemplares similares